Press Releases

 
Press Releases
  Date Title View
Feb 3, 2015
SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that InEK1, the German national system which prov...
Jan 12, 2015
Argus II is the First Approved ‘Bionic Eye' in Canada for the Treatment of Blindness due to Outer Retinal Degeneration SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of impla...
Dec 17, 2014
SYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore some functional vision to blind patients, today announced that it has entered into an exclusive agreement with ...
Nov 24, 2014
SYLMAR, Calif., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore some functional vision to blind patients, today announced that the underwriter for its initial public offering exercised its entire...
Nov 19, 2014
SYLMAR, Calif., Nov. 19, 2014 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. ("Second Sight") today announced the pricing of its initial public offering of 3,500,000 shares of common stock, at a price of $9.00 per share. Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blin...
Sep 18, 2014
Lausanne, Switzerland, 18th of September 2014 – Second Sight Medical Products Inc. (Second Sight) today announces the world’s first ever study that aims to establish whether blind patients with total central vision loss due to dry Age-Related Macular Degeneration (AMD) can benefit from an artificial retina – th...
Aug 18, 2014
Mar 31, 2014
Jan 29, 2014
Sylmar, CA, January 29, 2014 - Second Sight Medical Products Inc. (Second Sight) today announced that the Argus II Retinal Prosthesis System was implanted in patients with Retinitis Pigmentosa (RP) in the U.S. since it was approved by the U.S. Food and Drug Administration (FDA) last year.   This follows the fir...
Oct 29, 2013
Page: FirstPrevious ...
9
NextLast
= add release to Briefcase